Additional file 1 of Including non-concurrent control patients in the analysis of platform trials: is it worth it? (2020)

First Author: Lee K

Attributed to: Developing efficient perpetual platform trials to study multiple treatments and multiple biomarkers funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.6084/m9.figshare.12560717

Publication URI: https://springernature.figshare.com/articles/Additional_file_1_of_Including_non-concurrent_control_patients_in_the_analysis_of_platform_trials_is_it_worth_it_/12560717

Type: Other